Literature DB >> 30092296

Cynomorium songaricum prevents bone resorption in ovariectomized rats through RANKL/RANK/TRAF6 mediated suppression of PI3K/AKT and NF-κB pathways.

Xueqin Ma1, Jingjing Liu2, Lingling Yang2, Bo Zhang2, Yanhong Dong2, Qipeng Zhao3.   

Abstract

AIM: Cynomorium songaricum Rupr., an edible and important Traditional Chinese medicine has long been used in folk for treatment of kidney deficiency, was chosen to estimate the antiosteoporotic activity and underlying molecular mechanism on rats induced by ovariectomy (OVX). MAIN
METHODS: 9 of 45 rats were underwent bilateral laparotomy without removing the ovaries as sham group, remains were underwent bilateral ovariectomy and equally randomized into four groups: with vehicle (0.5% CMC-Na) as model group, estradiol valerate (1 mg/kg body weight/day) as positive control, with 100 and 300 mg/kg body weight/day of ethanol extracts of C. songaricum extract (CSE) as low and high dosage groups, respectively. KEY
FINDINGS: After 12 weeks of continues orally intervention, the decreases of bone mineral density, bone mineral content, tissue mineral content, as well as the increases of bone trabecular separation and bone resorption markers were significantly reversed by CSE in the OVX rats, and in particular, a contradictory phenomenon on calcium and phosphorus contents was observed and elucidated. Mechanistically, the expressions of tumor-necrosis factor receptor-associated factor 6 (TRAF 6), nuclear factor kappa B (RANK) and its ligand (RANKL), as well as the nuclear factor kappa B (NF-κB), phosphoinositide 3‑kinase (PI3K) and protein kinase B (AKT) levels were significantly down-regulated by CSE intervention, whereas the osteoprotegerin (OPG) was significantly up-regulated by CSE as compared to the control. SIGNIFICANCE: Concisely, C. songaricum exhibited potential therapeutic effect on bone metabolism of ovariectomized rats, and this effect was possibly exerted by RANKL/RANK/TRAF6 mediated down-regulation of NF-κB and PI3K/AKT pathways.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone formation; Bone resorption; Cynomorium songaricum Rupr.; Ovariectomized rats; TRAF6

Mesh:

Substances:

Year:  2018        PMID: 30092296     DOI: 10.1016/j.lfs.2018.08.008

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  A sustained-release Trametinib bio-multifunction hydrogel inhibits orthodontically induced inflammatory root resorption.

Authors:  Hang Yu; Zhina Wu; Xingfu Bao; Xiaoduo Tang; Junhu Zhang; Yi Zhang; Min Hu
Journal:  RSC Adv       Date:  2022-06-06       Impact factor: 4.036

2.  Anti-Osteoporotic Activity of an Edible Traditional Chinese Medicine Cistanche deserticola on Bone Metabolism of Ovariectomized Rats Through RANKL/RANK/TRAF6-Mediated Signaling Pathways.

Authors:  Bo Zhang; Ling-Ling Yang; Shu-Qin Ding; Jing-Jing Liu; Yan-Hong Dong; Yan-Ting Li; Nan Li; Xiao-Jun Zhao; Chang-Ling Hu; Yiping Jiang; Xue-Qin Ma
Journal:  Front Pharmacol       Date:  2019-11-26       Impact factor: 5.810

Review 3.  Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes.

Authors:  Emmanuelle Lautié; Olivier Russo; Pierre Ducrot; Jean A Boutin
Journal:  Front Pharmacol       Date:  2020-04-07       Impact factor: 5.810

4.  Effects of Icariin on Modulating Gut Microbiota and Regulating Metabolite Alterations to Prevent Bone Loss in Ovariectomized Rat Model.

Authors:  Shanshan Wang; Shengjie Wang; Xiaoning Wang; Yunteng Xu; Xin Zhang; Yidan Han; Hui Yan; Linglong Liu; Lili Wang; Hongzhi Ye; Xihai Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-24       Impact factor: 6.055

5.  Gadus morhua Eggs Sialoglycoprotein Prevent Estrogen Deficiency-Induced High Bone Turnover by Controlling OPG/RANKL/TRAF6 Pathway and Serum Metabolism.

Authors:  Meihui Zhao; Fengfeng Mei; Jinfeng Lu; Qingying Xiang; Guanghua Xia; Xueying Zhang; Zhongyuan Liu; Chenghui Zhang; Xuanri Shen; Qiuping Zhong
Journal:  Front Nutr       Date:  2022-04-12

6.  Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway.

Authors:  Biqiang Zhu; Yunwei Wei
Journal:  Cancer Med       Date:  2019-11-26       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.